We recently reported associations of body mass index (BMI)-adjusted body cell mass (BCMbmi) and BMI-adjusted lean body mass (LBMbmi) with metabolic markers, metabolic syndrome (MetS), and insulin resistance (IR) in middle-aged and older Korean adults.1 In the accompanying Letter, the author raised two important methodological considerations: the potential influence of the denominator on associations involving BCMbmi and the interpretation of differences between BCMbmi and LBMbmi. We thank the author for the opportunity to examine and clarify these issues.
First, we agree that associations involving a ratio-based measure may be influenced by its denominator.2 To assess this possibility, we conducted additional sex-stratified sensitivity analyses that included absolute BCM and BMI simultaneously as separate continuous variables. BCM and BMI were standardized within each sex. The models were adjusted for age, smoking status, alcohol consumption, regular exercise, household income, and marital status. Body weight was excluded because BMI was already included in the models.
After accounting for BMI, absolute BCM was not inversely associated with MetS or IR (Table 1). Among men, each one-standard-deviation increase in absolute BCM was associated with an odds ratio (OR) of 1.12 for MetS (95% confidence interval [CI], 1.02 to 1.23; P=0.017) and 0.94 for IR (95% CI, 0.85 to 1.02; P=0.148). Among women, the corresponding ORs were 1.21 for MetS (95% CI, 1.12 to 1.31; P<0.001) and 1.12 for IR (95% CI, 1.03 to 1.21; P=0.005).
Table 1.
Sex-stratified associations of absolute body cell mass and body mass index with metabolic syndrome and insulin resistance
| Outcome | Adjusted OR per 1-SD increment | 95% CI | P | |
|---|---|---|---|---|
| Metabolic syndrome | Male | 1.12 | 1.02–1.23 | 0.017 |
| Female | 1.21 | 1.12–1.31 | <0.001 | |
| Insulin resistance | Male | 0.94 | 0.85–1.02 | 0.148 |
| Female | 1.12 | 1.03–1.21 | 0.005 | |
ORs and 95% CIs were estimated using sex-stratified multivariable logistic regression models. Absolute body cell mass and body mass index were standardized within each sex and entered simultaneously as continuous variables. Models were adjusted for age, smoking status, alcohol consumption, regular exercise, household income, and marital status.
OR, odds ratio; SD, standard deviation; CI, confidence interval.
These findings show that the inverse associations observed for BCMbmi did not persist when absolute BCM and BMI were modeled separately. Therefore, our original findings should not be interpreted as evidence that greater absolute BCM was independently associated with lower odds of MetS or IR. BCMbmi is better interpreted as a relative body-composition index reflecting BCM in relation to BMI. Properties related to the denominator may have influenced the direction and magnitude of the observed associations.
Second, we agree that small differences in the area under the receiver operating characteristic curve do not necessarily indicate biologically or clinically meaningful superiority.3 Our findings did not consistently show better discrimination with BCMbmi. Discriminative performance was comparable between BCMbmi and LBMbmi among men, whereas LBMbmi showed slightly higher discrimination for several outcomes among women. Our study aimed to investigate BCM as a relatively understudied bioelectrical impedance-derived measure, not to establish its superiority over LBM.
We also examined whether absolute BCM and LBM could be included in the same multivariable model. The two measures were almost perfectly correlated among both men and women, with Pearson correlation coefficients of approximately 0.997. When BCM and LBM were simultaneously included, their variance inflation factors exceeded 180. The resulting coefficients were unstable and had opposite signs. Mutual adjustment therefore could not yield clinically interpretable estimates of the separate contributions of BCM and LBM. Statistical significance in these models should not be interpreted as evidence of an independent biological contribution.
Together, these additional analyses support a more cautious interpretation of BCMbmi. BCMbmi may serve as a complementary measure of relative body composition, but these cross-sectional findings do not establish an independent inverse association of absolute BCM or the superiority of BCM over conventional measures of lean mass. Future studies using prospectively specified body-composition models, repeated measurements, and longitudinal outcomes are needed to determine whether BCM provides incremental clinical information beyond BMI and established lean-mass measures.
Footnotes
CONFLICTS OF INTEREST
The authors declare no conflict of interest.
References
- 1.Cho S, Lee J, Yun JM, Kwon H. Association of body mass index-adjusted body cell mass and lean body mass with metabolic syndrome and insulin resistance in middle-aged and older adults: a cross-sectional study. J Obes Metab Syndr 2026;35:61-71. 10.7570/jomes25022 [DOI] [PMC free article] [PubMed]
- 2.Valente MJ, Cao B, Holthuijsen DDB, Bours MJL, Eussen SJPM, Weijenberg MP, et al. Omission of main effects from regression models with a ratio variable as the focal exposure can result in bias and inflated type I error rates. J Clin Epidemiol 2026;190:112092. 10.1016/j.jclinepi.2025.112092 [DOI] [PubMed]
- 3.Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007;115:928-35. 10.1161/CIRCULATIONAHA.106.672402 [DOI] [PubMed]
